Close
Nordic 9Nordic 9

Oncode Oncology Bridge Fund (investor - Venture Capital)

Netherlands oncodeinstitute.nl
See something wrong or missing? Let us know
Offices:Utrecht
Average round investment:11.14M USD
Average number per year:1.3
Distribution: 2026 (1)2025 (2)2024 (1)
Portfolio companies: Netherlands Laigo BioNetherlands CyclomicsNetherlands Flindr Therapeutics
Mostly invests in: Netherlands Netherlands (4) Health services (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Oncode Oncology Bridge Fund mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Oncode Oncology Bridge Fund

Name Criteria
Switzerland SAGANA
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Arab Emirates TVM Capital Healthcare
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Evonik Venture Capital GmbH
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Belgium Flanders Future Techfund (FFTF)
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Sweden Flerie Invest
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Netherlands Thuja Capital Management B.V.
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Edaphon
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Sweden SEB Venture Capital
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
Switzerland VI Partners AG
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Switzerland Wille Finance AG
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Top